Showing all 2 results

  • Erlocip Erlotinib Tablet PackErlocip Erlotinib Tablet Pack

    Erlocip (Erlotinib)

    0 out of 5
    Price range: $240 through $750

    Erlocip (Erlotinib Tablets) contains erlotinib, a tyrosine kinase inhibitor targeting EGFR mutations in non-small cell lung cancer (NSCLC). It disrupts tumor signaling and reduces progression. Taken orally under oncologist supervision, Erlocip supports prolonged disease control in patients with EGFR-positive NSCLC.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Xovoltib 50 mg Afatinib Tablet Pack

    Xovoltib 50 mg (Afatinib Dimaleate)

    0 out of 5
    Price range: $1,180 through $3,460

    Xovoltib 50 mg (Afatinib Dimaleate Tablets) contains afatinib, an irreversible EGFR tyrosine kinase inhibitor indicated for advanced or metastatic EGFR-mutant non-small cell lung cancer (NSCLC). Taken orally once daily, Xovoltib inhibits tumour growth and enhances progression-free survival under oncologist supervision.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content